Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia
Conditions: Relapsed Pediatric ALL; Relapsed Pediatric AML; Refractory Acute Myeloid Leukemia; Refractory Acute Lymphoblastic Leukemia Intervention: Drug: Daunorubicin Sponsor: Children's Mercy Hospital Kansas City Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials